FOLLOW-UP OF PATIENTS WITH HAIRY CELL LEUKEMIA AFTER TREATMENT WITH CLADRIBINE
<p>Background. The long-term outcome in 16 patients with hairy cell leukemia (HCL) treated with cladribine between 1995 and 2003 is reported.</p><p>Patients and methods. Cladribine was administered to 13 patients in a dose 0.1 mg/kg/day for 7 days, and the same daily dose was appli...
Main Author: | Peter Černelč |
---|---|
Format: | Article |
Language: | English |
Published: |
Slovenian Medical Association
2004-12-01
|
Series: | Zdravniški Vestnik |
Subjects: | |
Online Access: | http://vestnik.szd.si/index.php/ZdravVest/article/view/2420 |
Similar Items
-
Splenectomy versus cladribine therapy in hairy cell leukemia patients: a clinical trial
by: Jalaee Khoo H, et al.
Published: (2009-11-01) -
Clinical and Laboratory Presentation of Hairy Cell Leukemia (Hcl) and Rate of Response to Cladribine
by: M Forat Yazdi
Published: (2008-04-01) -
Severe Systemic Rash in the Treatment of Hairy Cell Leukemia with Cladribine: Case Report and Literature Review
by: Dong H, et al.
Published: (2020-11-01) -
Hairy cell leukemia and pregnancy
by: L S Al-radi, et al.
Published: (2017-07-01) -
Treatment for recurrent hairy cell leukemia.
by: L S Al'-Radi, et al.
Published: (2012-07-01)